Bars represent maximum radiance. PC. The PC reduced caspase-3 activation, increased the Akt, eNOS phosphorylation and VEGF levels.Invivodata in preconditioned group showed a robust cell anti-apoptosis, reduction in infarct size, and significant improvement Rabbit polyclonal to Smac in cardiac function. The effects of BK PC were abrogated by the B2 receptor antagonist HOE140, the Akt and eNOS antagonists LY294002 and L-NAME, respectively. == Conclusions == The activation of B2 receptor-dependent PI3K/Akt/eNOS pathway by BK Ethylmalonic acid PC promotes VEGF secretion, hEPC survival and inhibits apoptosis, thereby improving cardiac functioninvivo. The BK PC hEPC transplantation for stem cell-based therapies is a novel approach that has potential for clinical used. == Introduction == Stem cell-based therapies offer promising approaches to improve cardiac function after myocardial injury. Several studies have suggested that endothelial progenitor cells (EPCs) participate in the process of neovascularization and tissue repair to enhance the recovery of the ischemic myocardium [1,2]. Although stem cell transplantation shows great promise for cardiac reparative and regenerative therapy, the effectiveness of the engraftment and survival of the transplanted stem cells within the ischemic myocardium limits its use. A study reported only a few mesenchymal stem cell (MSC) survivors after 1-week injection of stem cells [3]. Ethylmalonic acid Our previous study also showed a limited number of EPC survivor at day 10 post myocardial infarction (MI) [4]. Apoptosis is considered as one of the mechanisms of cell death in the ischemic myocardium [5]. Therefore, strategies to decrease apoptosis are important for cell survival to regenerate cardiac function in the infarcted myocardium. Preconditioning (PC) of stem cells is a new strategy used to minimize the massive death of cells after transplantation [6]. Ischemic preconditioning (IPC) reportedly enhances the survival of stem cells during transplantation in the infarcted myocardium [7]. The PC of MSCs with diazoxide reportedly promotes the survival and angiomyogenic potential of MSCs in the infarcted myocardium [8]. Bradykinin (BK), the main metabolite in the tissue kallikrein-kinin system (KKS), reportedly has an important function in regulating the tolerance of an ischemic heart [9]. BK has been widely accepted as one of the endogenous protective factors for improving cardiac function, and attenuate cardiomyocyte apoptosis after myocardial injury [10]. The effect of BK is mediated by the B1 receptor (B1R) and B2 receptor (B2R) according to the relative Ethylmalonic acid potencies and affinities to their agonists [11]. B2R is constitutively expressed in human EPCs (hEPCs), whereas B1R is weakly expressed [12]. BK limits the infarct size in the ischemic heart during the late phase of PC by activating B2R [13]. Furthermore, BK PC can improve left ventricular performance and limit myocardial apoptosis [14]. However, the BK PC of stem cells prior to transplantation has not been reported thus far. In this study, we hypothesized that the PC hEPCs with BK will significantly enhance cell survival, inhibit apoptosis, and promote infarcted myocardium repair. == Materials and Methods == == Ethics Statement == The use of human cord blood in this study was approved by the Medical Ethics Committee of Zhongda Hospital Affiliated to Southeast University (approval ID: 2010 ZDLL05). A written informed consent was obtained from all selected pregnant women involved in the study. All animal studies were performed via a protocol approved by the Institutional Animal Care and Use Committee of Southeast University and complied with the National Research Councils guidelines (approval ID: SYXK-2010.0510). == Isolation, Culture and Characterization of hEPCs == Human umbilical cord blood was obtained from Zhongda Hospital in accordance with the approved institutional review board protocol. The obtained human umbilical cord blood was diluted to a 1:1 ratio in phosphate-buffered saline (PBS). The mononuclear cell (MNC) fraction was obtained from a Lymphoprep density gradient (Sigma) after centrifugation, washed twice in PBS, and centrifuged. The cell pellet was suspended in endothelial basal growth medium (EBM-2) supplemented with EGM-2 MV SingleQuots and 5% heat inactivated fetal bovine serum (FBS) (EGM-2, Lonza, Walkersville, MD, USA). The solution was plated in a T-25 culture ask coated with 10 g/ml human plasma bronectin (FN, Millipore, Bedford, MA, USA). After removing unbound cells at 96 hours with the bound cell fraction maintained in culture using EGM-2,.